Tagged: National Cancer Institute (NCI)

Breast cancer patients might not be getting full advantage from a genetic screening test for the protein known as HER2 to help determine if the use of trastuzumab (marketed as Herceptin) is the best course of treatment for them. For patients whose breast cancer cells produce excessive amounts of HER2, trastuzumab can be highly effective.

Scientists from the UCSF School of Pharmacy's Department of Pharmaceutical Chemistry have been selected to lead a new federal initiative aimed at developing new classes of drugs to target cancer.

The wider world use of medical tests and treatments based on individual genetic differences is the focus of a new, US$5 million research program funded by the National Cancer Institute (NCI) and led by UCSF School of Pharmacy health economist Kathryn Phillips, PhD.

Pharmacy school faculties across the United States will be trained to teach a tobacco cessation curriculum to Doctor of Pharmacy students, and community pharmacists and physicians will be trained to work as a close-knit team when it comes to helping their patients quit smoking because of two recently funded grants from the National Cancer Institute and the leadership of UCSF School of Pharmacy investigators Karen Hud